Dr. Mohammad Reza Mastali, MD

Dr. Mastali practices at AdventHealth Surgery Center Davenport in Davenport, Florida.

Dr. Mastali's NPI, 1689762924, was assigned on October 11, 2006. Dr. Mastali graduated from UT Southwestern Medical Center in 1995. Dr. Mastali holds Florida license ME 85686.

Dr. Mastali's primary practice is AdventHealth Surgery Center Davenport, at 107 Park Place Blvd, Davenport, FL 33837. The practice phone is (863) 419-2812.

Dr. Mastali's primary practice is AdventHealth Surgery Center Davenport in Davenport, Florida. Dr. Mastali is also affiliated with AdventHealth Heart of Florida. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Mastali to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mastali practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Mastali's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Mastali is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Mastali's licenses on file in 3 states: Florida, Texas and Hawaii.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroenteritis and gastrointestinal bleeding among the conditions Dr. Mastali treats.

CMS data shows 412 Medicare services from Dr. Mastali across 8 procedure codes in 2024, for 256 Medicare patients. Medicare paid $46,314 for them.

CMS counts 256 Medicare patients who saw Dr. Mastali in 2024. The largest group is 65 to 74, with 146 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mastali's median patient age at 60, with 52% women.

In 2024, Dr. Mastali wrote 305 Medicare Part D claims for 120 patients. 80% of them were for generic drugs. CMS names the drug for 225 of them, across 6 drugs with 11 or more claims each, at $30,161 in total drug cost. In 2023, CMS named 186 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Mastali for performance year 2024, reported as part of a group. Dr. Mastali accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 86 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Mastali, more than 73% of the clinicians it reports for that procedure.

CMS Open Payments shows 316 general payments to Dr. Mastali from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Abbvie Inc. paid the most, $1,629.

Dmand AI lists 1 award for Dr. Mastali, most recently CMS Stage 1 EHR in 2013.

Dr. Mastali graduated from UT Southwestern Medical Center in 1995.

Dr. Mastali is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.